MedAvail Holdings, Inc.
MDVL · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.01 | 0.05 | -0.00 |
| FCF Yield | -253.22% | -100.19% | -34.20% | -85.30% |
| EV / EBITDA | -0.37 | -0.94 | -1.67 | -1.48 |
| Quality | ||||
| ROIC | -166.48% | -138.92% | -31.43% | -197.28% |
| Gross Margin | 6.00% | 1.43% | 36.96% | 25.14% |
| Cash Conversion Ratio | 1.00 | 0.97 | 1.07 | 0.91 |
| Growth | ||||
| Revenue 3-Year CAGR | 45.59% | 80.37% | 238.54% | 92.82% |
| Free Cash Flow Growth | -9.08% | -55.54% | -47.64% | -513.78% |
| Safety | ||||
| Net Debt / EBITDA | 0.10 | 0.18 | 2.87 | -0.25 |
| Interest Coverage | -39.61 | -73.87 | -16.77 | -28.21 |
| Efficiency | ||||
| Inventory Turnover | 5.84 | 5.57 | 3.13 | 0.61 |
| Cash Conversion Cycle | 66.10 | 43.69 | 83.87 | 581.37 |